Novel Biomarkers and Therapeutic Targets for Melanoma.
adjuvant therapy
immunotherapy
malignant melanoma
targeted therapy
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
01 Oct 2022
01 Oct 2022
Historique:
received:
16
09
2022
revised:
23
09
2022
accepted:
23
09
2022
entrez:
14
10
2022
pubmed:
15
10
2022
medline:
18
10
2022
Statut:
epublish
Résumé
Malignant melanoma is one of the most common cancers in the world. In the disease's early stages, treatment involves surgery, in advanced stages however, treatment options were once scarce. There has been a paradigm shift in advanced melanoma treatment with the introduction of immunotherapy and targeted therapies. Understanding the molecular pathways and their pathologic counterparts helped identifying specific biomarkers that lead to the development of specific targeted therapies. In this review we briefly present some of these markers and their relevance to melanoma treatment.
Identifiants
pubmed: 36232957
pii: ijms231911656
doi: 10.3390/ijms231911656
pmc: PMC9570448
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
N Engl J Med. 2022 Jan 6;386(1):24-34
pubmed: 34986285
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Br J Cancer. 2013 Jan 15;108(1):193-8
pubmed: 23257896
N Engl J Med. 2018 May 10;378(19):1789-1801
pubmed: 29658430
Lancet Oncol. 2017 Apr;18(4):435-445
pubmed: 28284557
Clin Cancer Res. 2016 Feb 15;22(4):1018-27
pubmed: 26490311
J Natl Cancer Inst. 2003 Jun 4;95(11):806-12
pubmed: 12783935
Onco Targets Ther. 2017 Aug 08;10:3941-3947
pubmed: 28860801
Future Oncol. 2022 Jun;18(17):2041-2051
pubmed: 35272485
Int J Mol Sci. 2022 Mar 19;23(6):
pubmed: 35328746
N Engl J Med. 2019 Aug 15;381(7):626-636
pubmed: 31166680
Lancet. 2020 Jun 13;395(10240):1835-1844
pubmed: 32534646
Isr Med Assoc J. 2018 Dec;20(12):780-781
pubmed: 30550010
Cancers (Basel). 2021 Mar 17;13(6):
pubmed: 33802790
Cancer Res. 2014 Apr 15;74(8):2340-50
pubmed: 24576830
Cancer. 2012 Aug 15;118(16):4014-23
pubmed: 22180178
Eur J Cancer. 2021 Dec;159:113-124
pubmed: 34742158
Clin Cancer Res. 2015 May 15;21(10):2289-96
pubmed: 25695690
J Clin Oncol. 2012 Jun 20;30(18):2240-7
pubmed: 22547594
J Clin Oncol. 2022 May 1;40(13):1428-1438
pubmed: 35030011
Cancers (Basel). 2020 Jan 16;12(1):
pubmed: 31963119
J Natl Cancer Inst. 2015 Aug 20;107(11):
pubmed: 26296643
Yonsei Med J. 2020 Jul;61(7):562-571
pubmed: 32608199
J Clin Oncol. 2013 Jun 20;31(18):2337-46
pubmed: 23690423
J Immunother Cancer. 2020 Dec;8(2):
pubmed: 33361337
JCO Precis Oncol. 2018 Nov;2:1-11
pubmed: 35135154
Cancer. 1973 Dec;32(6):1446-57
pubmed: 4757934
J Natl Cancer Inst. 2003 Dec 17;95(24):1878-90
pubmed: 14679157
J Biol Chem. 2004 Jul 2;279(27):28220-6
pubmed: 15078889
Curr Treat Options Oncol. 2021 Feb 8;22(3):20
pubmed: 33558987
J Clin Oncol. 2011 Apr 1;29(10):1239-46
pubmed: 21343559
Semin Radiat Oncol. 2002 Oct;12(4):319-28
pubmed: 12382190
N Engl J Med. 2017 Nov 9;377(19):1813-1823
pubmed: 28891408
J Hematol Oncol. 2021 Jan 5;14(1):2
pubmed: 33402214
J Clin Oncol. 2011 Jul 20;29(21):2904-9
pubmed: 21690468
Pigment Cell Melanoma Res. 2018 Jul;31(4):484-495
pubmed: 29385656
Lab Invest. 2017 Feb;97(2):146-157
pubmed: 28067895
Ann Oncol. 2017 Jun 01;28(6):1380-1387
pubmed: 28327988
Cancers (Basel). 2020 Jul 07;12(7):
pubmed: 32645881
Arch Pathol Lab Med. 2020 Apr;144(4):500-522
pubmed: 32057276
Eur J Cancer. 2019 Feb;108:25-32
pubmed: 30605822
BMC Cancer. 2018 Oct 23;18(1):1029
pubmed: 30352569
Lancet Oncol. 2019 Jul;20(7):948-960
pubmed: 31160251
Clin Cancer Res. 2011 Jan 15;17(2):229-35
pubmed: 20975100
Onco Targets Ther. 2021 Jun 09;14:3709-3719
pubmed: 34135599
Int J Mol Sci. 2020 Jul 09;21(14):
pubmed: 32659938
Front Immunol. 2021 Jul 22;12:699895
pubmed: 34367161
Genes Cancer. 2018 May;9(5-6):176-189
pubmed: 30603054
Radiat Oncol. 2021 Sep 18;16(1):181
pubmed: 34537078
Eur J Cancer. 2021 Nov;157:348-357
pubmed: 34562816
Genomics. 1991 Apr;9(4):629-41
pubmed: 1674727
Cancer Res. 2010 Jul 1;70(13):5549-57
pubmed: 20516123
Oncogene. 2007 May 14;26(22):3100-12
pubmed: 17496909
N Engl J Med. 2005 Nov 17;353(20):2135-47
pubmed: 16291983
Acta Oncol. 2020 Jul;59(7):833-844
pubmed: 32285732
Clin Adv Hematol Oncol. 2022 Jun;20(6):359-361
pubmed: 35731606
Nature. 2005 Jul 7;436(7047):117-22
pubmed: 16001072
Clin Cancer Res. 2012 Jun 15;18(12):3242-9
pubmed: 22535154
N Engl J Med. 2015 Jun 25;372(26):2521-32
pubmed: 25891173
Cancer Invest. 2012 May;30(4):251-7
pubmed: 22480210
Lancet. 2022 Apr 30;399(10336):1718-1729
pubmed: 35367007
Melanoma Res. 2018 Aug;28(4):259-270
pubmed: 29746316
Eur J Cancer. 2010 May;46(8):1413-20
pubmed: 20189796
Lancet. 2012 Jul 28;380(9839):358-65
pubmed: 22735384
ESMO Open. 2021 Aug;6(4):100223
pubmed: 34388689